Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-22 Pay Paul William Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-04-22 van der Velden Peter Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-04-22 Sistilli Carlo Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-04-22 OAKES FRANK R. Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-04-22 MacDonald Sean Arthur Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-03-25 Nijhawan Pardeep Chief Executive Officer Purchase +3,000 $5.25 $16K 545,312
2021-03-25 Brooks Michael J President Purchase +3,500 $5.19 $18K 13,241
2021-03-24 Brooks Michael J President Purchase +4,500 $5.08 $23K 9,741
2021-03-24 Nijhawan Pardeep Chief Executive Officer Purchase +5,000 $5.16 $26K 542,312
2021-02-18 OAKES FRANK R. Director Sale −1,827 $7.25 $13K 0
2021-02-18 OAKES FRANK R. Director Sale −6,165 $7.25 $45K 0
2020-11-09 JOHNSON LORIN K Director Option exercise +4,262 $4.00 $17K 12,786
2020-11-09 JOHNSON LORIN K Director Option exercise · Common Share Warrants (Right to Buy) −4,262 0
2020-11-06 Pay Paul William Director Option exercise +1,218 $4.00 $5K 3,654
2020-11-06 Pay Paul William Director Option exercise · Common Share Warrants (Right to Buy) −1,218 0
2020-11-06 Brooks Michael J President Option exercise +914 $4.00 $4K 5,241
2020-11-06 Brooks Michael J President Option exercise · Common Share Warrants (Right to Buy) −914 0
2020-11-06 NIFFENEGGER KATHI Chief Financial Officer Option exercise +609 $4.00 $2K 1,827
2020-11-06 NIFFENEGGER KATHI Chief Financial Officer Option exercise · Common Share Warrants (Right to Buy) −609 0
2020-11-05 Sistilli Carlo Director Option exercise +1,218 $4.00 $5K 3,654

Page 8 of 15 · 284 trades